Colton Jones
Tracked across 1 events · 45 articles · First seen Jun 02, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Colton Jones>>> presented a study at ASCO finding GLP-1s were associated with lower rates of new prostate cancer diagnoses, hypothesizing both weight loss and direct anti-cancer effects.
Jun 02, 2026 · 45 articles
70
Colton Jones presented studyGLP-1 Drugs Reduce Cancer Risk
ERGEN INTELLIGENCE
Track Colton Jones live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard